Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3244–3247. doi: 10.1128/jcm.35.12.3244-3247.1997

Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups.

V Fingerle 1, J L Goodman 1, R C Johnson 1, T J Kurtti 1, U G Munderloh 1, B Wilske 1
PMCID: PMC230155  PMID: 9399527

Abstract

To date, human granulocytic ehrlichiosis (HGE), the causative agent of which is likely transmitted by ticks in the Ixodes ricinus-Ixodes persulcatus complex, has not been diagnosed with certainty in patients outside the United States. The presence of a closely related vector tick, I. ricinus, as well as the occurrence of similar Ehrlichia spp. of veterinary importance, suggests that this disease is likely to be present in Europe. The aim of the present study was to compare the prevalence of antibodies against the HGE agent in sera collected from patients in groups at high risk for exposure to I. ricinus with that of a control population. Risk groups consisted of 150 forestry workers and 105 patients with an established diagnosis of Lyme disease. The control group was 103 healthy blood donors without a history of tick bites. We used a patient isolate of the HGE agent from Minnesota (J. L. Goodman, C. Nelson, B. Vitale, J. E. Madigan, J. S. Dumler, T. J. Kurtti, and U. G. Munderloh, N. Engl. J. Med. 334:209-215, 1996) propagated in HL60 cells as the source of antigen for a specific immunofluorescence assay (IFA). Elevated IFA titers (> or = 1:80) were present in 21 of 150 (14%) serum samples from forestry workers and in 12 of 105 (11.4%) serum samples from Lyme disease patients, but in only 2 of 103 (1.9%) serum samples from blood donors (P < or = 0.01 for either of the at-risk groups versus blood donors). The results of this study suggest that the HGE agent or a closely related organism exists in southern Germany and that seroconversion to it is common among groups exposed to Ixodes ticks. Final proof that HGE occurs in Germany will require the isolation of the causative agent from patients. HGE should be considered in the differential diagnosis of febrile illnesses in individuals exposed to Ixodes ticks in Europe as well as in North America.

Full Text

The Full Text of this article is available as a PDF (137.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson B. E., Dawson J. E., Jones D. C., Wilson K. H. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol. 1991 Dec;29(12):2838–2842. doi: 10.1128/jcm.29.12.2838-2842.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakken J. S., Dumler J. S., Chen S. M., Eckman M. R., Van Etta L. L., Walker D. H. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA. 1994 Jul 20;272(3):212–218. [PubMed] [Google Scholar]
  3. Bakken J. S., Krueth J., Wilson-Nordskog C., Tilden R. L., Asanovich K., Dumler J. S. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996 Jan 17;275(3):199–205. [PubMed] [Google Scholar]
  4. Barlough J. E., Madigan J. E., DeRock E., Dumler J. S., Bakken J. S. Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent). J Clin Microbiol. 1995 Dec;33(12):3333–3334. doi: 10.1128/jcm.33.12.3333-3334.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brenner D. J., O'Connor S. P., Winkler H. H., Steigerwalt A. G. Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol. 1993 Oct;43(4):777–786. doi: 10.1099/00207713-43-4-777. [DOI] [PubMed] [Google Scholar]
  6. Brouqui P., Dumler J. S., Lienhard R., Brossard M., Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet. 1995 Sep 16;346(8977):782–783. doi: 10.1016/s0140-6736(95)91544-3. [DOI] [PubMed] [Google Scholar]
  7. Büscher G., Gandras R., Apel G., Friedhoff K. T. Der erste Fall von Ehrlichiosis beim Pferd in Deutschland (Kurzmitteilung). Dtsch Tierarztl Wochenschr. 1984 Nov 22;91(11-12):408–409. [PubMed] [Google Scholar]
  8. Chen S. M., Dumler J. S., Bakken J. S., Walker D. H. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 1994 Mar;32(3):589–595. doi: 10.1128/jcm.32.3.589-595.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dumler J. S., Asanovich K. M., Bakken J. S., Richter P., Kimsey R., Madigan J. E. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia. J Clin Microbiol. 1995 May;33(5):1098–1103. doi: 10.1128/jcm.33.5.1098-1103.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Engvall E. O., Pettersson B., Persson M., Artursson K., Johansson K. E. A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol. 1996 Sep;34(9):2170–2174. doi: 10.1128/jcm.34.9.2170-2174.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goodman J. L., Nelson C., Vitale B., Madigan J. E., Dumler J. S., Kurtti T. J., Munderloh U. G. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med. 1996 Jan 25;334(4):209–215. doi: 10.1056/NEJM199601253340401. [DOI] [PubMed] [Google Scholar]
  12. Klein M. B., Nelson C. M., Goodman J. L. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother. 1997 Jan;41(1):76–79. doi: 10.1128/aac.41.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Magnarelli L. A., Dumler J. S., Anderson J. F., Johnson R. C., Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol. 1995 Nov;33(11):3054–3057. doi: 10.1128/jcm.33.11.3054-3057.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Magnarelli L. A., Stafford K. C., 3rd, Mather T. N., Yeh M. T., Horn K. D., Dumler J. S. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol. 1995 Oct;33(10):2710–2714. doi: 10.1128/jcm.33.10.2710-2714.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mitchell P. D., Reed K. D., Hofkes J. M. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol. 1996 Mar;34(3):724–727. doi: 10.1128/jcm.34.3.724-727.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Munderloh U. G., Madigan J. E., Dumler J. S., Goodman J. L., Hayes S. F., Barlough J. E., Nelson C. M., Kurtti T. J. Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol. 1996 Mar;34(3):664–670. doi: 10.1128/jcm.34.3.664-670.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Münchhoff P., Wilske B., Preac-Mursic V., Schierz G. Antibodies against Borrelia burgdorferi in Bavarian forest workers. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):412–419. doi: 10.1016/s0176-6724(87)80101-3. [DOI] [PubMed] [Google Scholar]
  18. Nicholson W. L., Comer J. A., Sumner J. W., Gingrich-Baker C., Coughlin R. T., Magnarelli L. A., Olson J. G., Childs J. E. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol. 1997 Jun;35(6):1510–1516. doi: 10.1128/jcm.35.6.1510-1516.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pancholi P., Kolbert C. P., Mitchell P. D., Reed K. D., Jr, Dumler J. S., Bakken J. S., Telford S. R., 3rd, Persing D. H. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis. 1995 Oct;172(4):1007–1012. doi: 10.1093/infdis/172.4.1007. [DOI] [PubMed] [Google Scholar]
  20. Petrovec M., Lotric Furlan S., Zupanc T. A., Strle F., Brouqui P., Roux V., Dumler J. S. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol. 1997 Jun;35(6):1556–1559. doi: 10.1128/jcm.35.6.1556-1559.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reed K. D., Mitchell P. D., Persing D. H., Kolbert C. P., Cameron V. Transmission of human granulocytic ehrlichiosis. JAMA. 1995 Jan 4;273(1):23–23. [PubMed] [Google Scholar]
  22. Rikihisa Y. The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev. 1991 Jul;4(3):286–308. doi: 10.1128/cmr.4.3.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sumption K. J., Wright D. J., Cutler S. J., Dale B. A. Human ehrlichiosis in the UK. Lancet. 1995 Dec 2;346(8988):1487–1488. doi: 10.1016/s0140-6736(95)92502-3. [DOI] [PubMed] [Google Scholar]
  24. Walker D. H., Dumler J. S. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis. 1996 Jan-Mar;2(1):18–29. doi: 10.3201/eid0201.960102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilske B., Fingerle V., Herzer P., Hofmann A., Lehnert G., Peters H., Pfister H. W., Preac-Mursic V., Soutschek E., Weber K. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol. 1993 Nov;182(5):255–270. doi: 10.1007/BF00579624. [DOI] [PubMed] [Google Scholar]
  26. Wormser G. P., Horowitz H. W., Dumler J. S., Schwartz I., Aguero-Rosenfeld M. False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet. 1996 Apr 6;347(9006):981–982. doi: 10.1016/s0140-6736(96)91475-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES